LMG Life Sciences Awards 2019 – shortlists announced
July 19, 2019
Ceremony will take place on Sept. 18 at Essex House in New York
US
Hatch-Waxman Patent Litigation (Generic)
| Hatch-Waxman Patent Litigation (Generic) — Highly recommended |
|---|
| Goodwin Procter |
| Knobbe Martens |
| Rakoczy Molino Mazzochi Siwik |
| Sterne Kessler Goldstein & Fox |
| Wilson Sonsini Goodrich & Rosati |
| Winston & Strawn |
| Hatch-Waxman Patent Litigation (Generic) — Recommended |
|---|
| Greenberg Traurig |
| Latham & Watkins |
| Morrison & Foerster |
| Perkins Coie |
| Robins Kaplan |
| Rothwell Figg Ernst & Manbeck |
| Taft Stettinius & Hollister |
| Willkie Farr & Gallagher |
| Lawyer | Section | Practice Area | Location |
|---|---|---|---|
| Holdreith, Jake M | Intellectual Property | General Patent Litigation, Patent Strategy & Management, Hatch-Waxman Patent Litigation | Minneapolis |
| Schutz, Ronald J | Intellectual Property | General Patent Litigation, Hatch-Waxman Patent Litigation | New York City |
| , {{displayValue}} {{displayValue}} {{displayValue}} | , {{displayValue}} {{displayValue}} {{displayValue}} | , {{displayValue}} {{displayValue}} {{displayValue}} | , {{displayValue}} {{displayValue}} {{displayValue}} |
Intellectual Property
Robins Kaplan
Robins Kaplan's life sciences group is made of almost 30 attorneys, a number of whom contribute to the firm's notable ranking in Hatch-Waxman disputes for generic drug makers. According to a client, the firm is "thoughtful and methodical in its work on our behalf in a number of high-stakes litigation matters," and "repeatedly demonstrates that our interests are 'top of mind' for them."
Jake Holdreith serves as life sciences industry lead at the firm, and is focused on representing generic drug companies in patent litigation. He recently secured a dismissal for Collegium in an action brought by Purdue Pharma alleging the client's updated clinical information infringed its patents. "Jake is not just a lawyer, he is an advisor," a client says. "He has a knack for understanding not only the legal ramifications of litigation strategy, but also how they interplay with business strategy."
Ronald Schutz is another one of the firm's distinguished IP trial lawyers, and serves as managing partner of the New York office. He has been active for client Puget Bioventures in multiple patent suits, including one case that resulted in a stay being lifted after Puget's patent claims were upheld by the Patent Office.
Articles
Ceremony will take place on Sept. 18 at Essex House in New York